These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9267892)
1. Amniotic fluid and maternal serum levels of CA125 in pregnancies affected by Down syndrome: a re-evaluation of the role of CA125 in Down syndrome screening. Spencer K; Muller F; Aitken DA Prenat Diagn; 1997 Aug; 17(8):701-6. PubMed ID: 9267892 [TBL] [Abstract][Full Text] [Related]
2. Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies. Wallace EM; Marjono B; Brown DA; Crossley J; Tong S; Aitken D; Breit S Prenat Diagn; 2004 Mar; 24(3):224-6. PubMed ID: 15057958 [TBL] [Abstract][Full Text] [Related]
3. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies. Noci I; Borri P; Biagiotti R; Cariati E; Branconi F; Torricelli F; Cappelli G; D'Agata A J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617 [TBL] [Abstract][Full Text] [Related]
4. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies. Hsu JJ; Hseih TT; Liou JD; Soong YK J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053 [TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of trisomy 21 in amniotic fluid. Spencer K; Muller F; Aitken DA Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826 [TBL] [Abstract][Full Text] [Related]
7. Abnormal amniotic fluid levels of CA 125 in second-trimester Down syndrome pregnancies. Borri P; Noci I; Biagiotti R; Torricelli F; D'Agata A; Croci D; Branconi F Prenat Diagn; 1993 Dec; 13(12):1095-9. PubMed ID: 8177829 [TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome. Wallace EM; D'Antona D; Shearing C; Evans LW; Thirunavukarasu P; Ashby JP; Shade M; Groome NP Clin Endocrinol (Oxf); 1999 May; 50(5):669-73. PubMed ID: 10468934 [TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome. Wenstrom KD; Owen J; Boots L Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585 [TBL] [Abstract][Full Text] [Related]
10. Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome. Laudanski P; Zbucka-Kretowska M; Charkiewicz K; Wolczynski S; Wojcik D; Charkiewicz R Mediators Inflamm; 2014; 2014():835837. PubMed ID: 25477715 [TBL] [Abstract][Full Text] [Related]
12. Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome. Davis RO; Cosper P; Huddleston JF; Bradley EL; Finley SC; Finley WH; Milunsky A Am J Obstet Gynecol; 1985 Nov; 153(5):541-4. PubMed ID: 2414991 [TBL] [Abstract][Full Text] [Related]
13. Second-trimester cancer antigen 125 and Down's syndrome. Van Blerk M; Smitz J; De Catte L; Kumps C; Van der Elst J; Van Steirteghem AC Prenat Diagn; 1992 Dec; 12(12):1062-6. PubMed ID: 1287642 [TBL] [Abstract][Full Text] [Related]
14. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA; Spencer K; Abushoufa RA Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [TBL] [Abstract][Full Text] [Related]
15. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Perrone S; Longini M; Bellieni CV; Centini G; Kenanidis A; De Marco L; Petraglia F; Buonocore G Clin Biochem; 2007 Feb; 40(3-4):177-80. PubMed ID: 17208212 [TBL] [Abstract][Full Text] [Related]
16. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]